Abstract:Dosage-sensitive genes have characteristic patterns of evolution that include being refractory to small-scale duplication, depleted on human benign copy number variants (CNVs) and enriched on pathogenic CNVs. This intolerance to copy number change is likely due to an expression constraint that exists in one or more tissues. While genomic copy number changes alter the encompassed genes' expression across all tissues, expression quantitative trait loci (eQTLs) {genomic regions harbouring sequence variants that influence the expression level of one or more genes) can act in a tissue-specific manner. In this work we examine expression variation of presumed dosage-sensitive and non-dosage-sensitive genes to discover how the locus duplicability constraints translate into gene expression constraints. Here we test the hypothesis that expression changes due to the presence of eQTLs acting in unconstrained tissues will not be deleterious and thus allow dosage-sensitive genes to vary expression while obeying constraints in other tissues. Using eQTLs across 48 human tissues from The Genotype-Tissue Expression (GTEx) project , we find that dosage-sensitive genes are enriched for being affected by eQTLs and that the eQTLs affecting dosage-sensitive genes are biased towards having narrow tissue-specificity with these genes having fewer eQTL-affected tissues than non-dosage-sensitive genes. Additionally, we find that dosage-sensitive genes are depleted for being affected by broad tissue breadth eQTLs, likely due to the increased chance of these eQTLs conflicting with expression constraints and being removed by purifying selection. These patterns suggest that dosage-sensitivity shapes the evolution of these genes by precluding copy number evolution and restricting their evolutionary trajectories to changes in expression regulation compatible with their functional constraints. Thus deeper interpretation of the patterns of constraints can be informative of the temporal or spatial location of the gene dosage sensitivity and contribute to our understanding of functional genomics.

Evolution of dosage-sensitive genes by tissue-restricted expression changes

Copy number variation alters local and global mutational tolerance

Multilevel gene expression changes in lineages containing adaptive copy number variants

Measurement of selective constraint on human gene expression

Uncovering genetic regulatory network divergence between duplicate genes using yeast eQTL landscape.

An Evolutionary Perspective on the Impact of Genomic Copy Number Variation on Human Health

Tissue-driven Hypothesis of Genomic Evolution and Sequence-Expression Correlations

In vivo response to high-resolution variation of Tbx1 mRNA dosage.

Modulation of Global Gene Expression by Aneuploidy and CNV of Dosage Sensitive Regulatory Genes

Non-linear transcriptional responses to gradual modulation of transcription factor dosage

Buffering and non-monotonic behavior of gene dosage response curves for human complex traits

Natural variation in the consequences of gene overexpression and its implications for evolutionary trajectories

Evidence for Weak Selective Constraint on Human Gene Expression.

Evolution of gene regulation during transcription and translation.

The Role of Cis-Regulatory Motifs and Genetical Control of Expression in the Divergence of Yeast Duplicate Genes

Recalibrating differential gene expression by genetic dosage variance prioritizes functionally relevant genes

Probing the limits of cis-acting gene regulation using a model of allelic imbalance quantitative trait loci

Differences in 5'untranslated regions highlight the importance of translational regulation of dosage sensitive genes

Phase separation as a possible mechanism for dosage sensitivity

Gene balance hypothesis: Connecting issues of dosage sensitivity across biological disciplines

Haplotype-aware modeling of cis-regulatory effects highlights the gaps remaining in eQTL data